Paul Schimmel Net Worth & Insider Trades

Paul Schimmel - Director, Atyr Pharma Inc

As of April 28, 2022

What is Paul Schimmel's Net Worth?

The current estimated net worth of Atyr Pharma Inc's Director, Paul Schimmel, is estimated to be about $190.5M . Paul Schimmel owns about 792,166 units of Atyr Pharma Inc common stock. In the last 7 years at Atyr Pharma Inc, Paul Schimmel has sold an estimated value of $30.74K worth.

What is Paul Schimmel's Past Insider Trading?

Paul Schimmel's largest purchase order was 500,000 units , worth over $2M on September 22, 2021. Paul Schimmel's largest sale order was 8,447 units , worth over $30.74K on May 22, 2020. In total, Paul Schimmel has made about 30 transactions over 7 years of their time at Atyr Pharma Inc. Paul Schimmel usually trades in April, with the busiest year in 2016.

PAUL SCHIMMEL

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Paul Schimmel's' Mailing Address?

  • Mailing address is 88 Sidney St Cambridge MA 02139 MA

Atyr Pharma Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Sanjay S. Shukla, M.D., M.S. 2020 $470,250 $223,369 $381,811 $223,369 $8,427 $1,083,857
Sanjay S. Shukla, M.D., M.S. 2019 $450,000 $95,625 $82,400 $95,625 $10,076 $663,961
Jill M. Broadfoot 2020 $365,750 $138,985 $182,671 $138,985 $11,374 $698,780
Jill M. Broadfoot 2019 $350,000 $59,500 $20,600 $59,500 $11,594 $454,624
Nancy E. Denyes 2020 $350,075 $116,400 $148,121 $116,400 $10,661 $625,257
Nancy E. Denyes 2019 $335,000 $49,831 $51,500 $49,831 $12,932 $449,263
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1339970/000156459021014935/life-def14a_20210428.htm

What are Atyr Pharma Inc's Past Insider Trades?

Atyr Pharma Inc's most recent insider trade came on February 6, 2023 by Marie Jill Broadfoot who sold 1,566 units worth $3.7K . In the last 8 years, insiders at Atyr Pharma Inc have sold an estimated value of $3.13M and bought an estimated value of $16.51M worth of shares. Insider trading is most common in May, with the busiest year in 2016. The most active traders at the company are Paul Schimmel, Director,  Sanjay Shukla, President and CEO,  and John Mendlein, Director .

aTYR PHARMA INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...